ASX:MDR MedAdvisor (MDR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About MedAdvisor Stock (ASX:MDR) 30 days 90 days 365 days Advanced Chart Get MedAdvisor alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume719,064 shsAverage VolumeN/AMarket CapitalizationA$91.07 millionP/E Ratio114.55Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia. Read More Receive MDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAdvisor and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDR Stock News HeadlinesMedAdvisor Limited Relocates Registered Office to Enhance OperationsSeptember 3, 2025 | tipranks.comMedAdvisor Limited Announces Director DepartureSeptember 1, 2025 | tipranks.com$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold stocks — in past bull markets, these plays delivered gains as high as 5,000% to 9,800%, and Sean has now identified five companies he believes could see explosive moves in the early stages of what may be the biggest gold rally yet.September 14 at 2:00 AM | Weiss Ratings (Ad)MedAdvisor Limited Faces Significant Financial Losses in 2025August 28, 2025 | tipranks.comMedAdvisor Reports FY25 Financial Results Amid Strategic ShiftAugust 28, 2025 | tipranks.comMedAdvisor Limited Announces Strategic Board Changes Post-ANZ SaleAugust 28, 2025 | tipranks.comLiberia: Up, MDR and CDC Parties' Offices Shut Down in Vote-Rich Nimba CountyAugust 22, 2025 | msn.comMedAdvisor Limited Shares Investor Insights Amidst Market UncertaintiesJuly 30, 2025 | tipranks.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:MDR CIKN/A Webwww.medadvisor.com.au Phone61 3 9095 3036FaxN/AEmployees31,900Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio114.55 Forward P/E RatioN/A P/E GrowthN/ANet Income-A$9.03 million Net Margins0.65% Pretax MarginN/A Return on Equity1.48% Return on Assets1.79% Debt Debt-to-Equity Ratio24.44 Current Ratio0.71 Quick Ratio0.47 Sales & Book Value Annual SalesA$122.11 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.95 Book ValueA$0.09 per share Price / BookN/AMiscellaneous Outstanding Shares551,310,000Free FloatN/AMarket CapA$91.07 million OptionableNot Optionable Beta0.67 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ASX:MDR) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAdvisor Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share MedAdvisor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
